EBV BALF-4 276-284 (HLA-A*02:01)

EBV BALF-4 276-284 (HLA-A*02:01)
€50.00 *

Prices plus VAT plus shipping costs

Delivery time 2-3 days
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

make your choice

  • EP11237_1
FLDKGTYTL is a linear peptidic epitope (epitope ID16548) studied as part of Envelope glycoprotein... more
Product information "EBV BALF-4 276-284 (HLA-A*02:01)"
FLDKGTYTL is a linear peptidic epitope (epitope ID16548) studied as part of Envelope glycoprotein B from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays Antigen Peptide EBV BALF-4 276ï¾–284 (HLA-A*02:01) FLDKGTYTL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.FLDKGTYTL is a linear peptidic epitope (epitope ID16548) studied as part of Envelope glycoprotein B from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays Antigen Peptide EBV BALF-4 276ï¾–284 (HLA-A*02:01) FLDKGTYTL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

 
Sequence:FLDKGTYTL
Gene:BALF4
Delivery: 2-3 days
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Envelope glycoprotein B
Species:EBV
Allele:HLA-A*02:01
Application :Flow Cytometry
Indication :Autoimmune disease, Burkitt's lymphoma, Hodgkin's lymphoma, Nasopharyngeal carcinoma
Dokumente - Protokolle - Downloads more
Viewed